Self-Orienting Syringe and Syringe Interface
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 14/526,294, filed Oct 28, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,173,995 | Self-Orienting Syringe and Syringe Interface In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| US 9,700,670 | Self-Orienting Syringe and Syringe Interface In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| US 10,245,375 | Self-Orienting Syringe and Syringe Interface In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| US 12,447,271 | Self-Orienting Syringe and Syringe Interface In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| US 11,419,977 | Self-Orienting Syringe and Syringe Interface In force · High confidence | Bayer Healthcare LLC | In force | High confidence | ||
| Application 19/360,580 | Self-Orienting Syringe and Syringe Interface Pending Not granted | Bayer Healthcare LLC | Pending | Not granted | not computed |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Bayer AG.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.